Bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+)
C30H16F6N8O2Ru — CID 139131626
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+)
Bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+) (PubChem CID 139131626) has the molecular formula C30H16F6N8O2Ru and a molecular weight of 735.57 g/mol. Its IUPAC name is bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+).
Molecular Properties
| Compound Name | Bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+) |
|---|---|
| PubChem CID | 139131626 |
| Molecular Formula | C30H16F6N8O2Ru |
| Molecular Weight | 735.57 g/mol |
| Exact Mass | 736.03 |
| IUPAC Name | bis((6-pyridin-2-yl-2-pyridinyl)-[3-(trifluoromethyl)pyrazol-1-id-5-yl]methanone);ruthenium(2+) |
| SMILES | O=C(c1cccc(-c2ccccn2)n1)c1cc(C(F)(F)F)n[n-]1.O=C(c1cccc(-c2ccccn2)n1)c1cc(C(F)(F)F)n[n-]1.[Ru+2] |
| InChI | InChI=1S/2C15H9F3N4O.Ru/c2*16-15(17,18)13-8-12(21-22-13)14(23)11-6-3-5-10(20-11)9-4-1-2-7-19-9;/h2*1-8H,(H,21,22,23);/q;;+2/p-2 |
| InChIKey | QIBOBIQUTSABOA-UHFFFAOYSA-L |
| XLogP | 5.49 |
| TPSA | 139.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 735.57 |
| LogP ≤ 5 | 5.49 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139131626 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.